Clinical Trials

Showing trials with last updates posted in 2025.

NCT05660850 | COMPLETED | PHASE2
49 participants

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-16
Start Date:
2023-03-22
Completion:
2024-10-20
Conditions
  • Chronic Refractory Cough (CRC) With Non-atopic Asthma
  • CRC With Atopic Asthma
  • Unexplained Chronic Cough
  • CRC With Chronic Obstructive Pulmonary Disease
  • CRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Interventions
  • DRUG
  • OTHER
  • DIAGNOSTIC_TEST
NCT05651594 | RECRUITING | PHASE2
40 participants

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-16
Start Date:
2023-03-07
Completion:
2029-03-30
Conditions
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Locally Advanced Esophageal Adenocarcinoma
  • Locally Advanced Gastroesophageal Junction Adenocarcinoma
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05617599 | RECRUITING
508 participants

SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Study Type:
OBSERVATIONAL
Last Updated:
2025-12-16
Start Date:
2023-05-10
Completion:
2026-12-01
Conditions
  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease
Interventions
  • DEVICE
No Results Yet
NCT05367063 | COMPLETED | PHASE4
45 participants

Canagliflozin and Myocardial Fibrosis

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-16
Start Date:
2022-01-05
Completion:
2024-12-31
Conditions
  • Type 2 Diabetes
  • Cardiovascular Risk
Interventions
  • DRUG
No Results Yet
NCT05253287 | COMPLETED | PHASE2/PHASE3
96 participants

Growth Hormone in Decompensated Liver Cirrhosis

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-16
Start Date:
2022-02-01
Completion:
2024-12-31
Conditions
  • Liver Cirrhosis
  • Fibrosis
  • End Stage Liver Disease
  • Digestive System Disease
  • Physiological Effect of Drugs
  • Growth Hormone Treatment
  • Sarcopenia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page